Logo image of CCRN

CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Analyst Ratings

NASDAQ:CCRN - Nasdaq - US2274831047 - Common Stock - Currency: USD

18.245  +0.01 (+0.03%)

Buy % Consensus

52

ChartMill assigns a Buy % Consensus number of 52% to CCRN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.81. This target is -2.4% below the current price.
CCRN was analyzed by 13 analysts. The buy percentage consensus is at 52. So analysts seem to be rather neutral about CCRN.
In the previous month the buy percentage consensus was at a similar level.
CCRN was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
CCRN Historical Analyst RatingsCCRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15

Price Target & Forecast

Price Low Median Mean High 18.2514.1418.9817.8119.54 - -22.50% 4.04% -2.40% 7.10%
CCRN Current Analyst RatingCCRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-02-06 JMP Securities Reiterate Market Perform -> Market Perform
2024-12-10 Barrington Research Downgrade Outperform -> Market Perform
2024-12-05 Truist Securities Maintains Hold -> Hold
2024-11-07 Benchmark Maintains Buy -> Buy
2024-10-21 Truist Securities Maintains Hold -> Hold
2024-08-08 Barrington Research Maintains Outperform -> Outperform
2024-08-01 Truist Securities Maintains Hold -> Hold
2024-05-06 Barrington Research Maintains Outperform -> Outperform
2024-05-02 Benchmark Maintains Buy -> Buy
2024-02-27 Barrington Research Maintains Outperform -> Outperform
2024-02-22 Benchmark Maintains Buy -> Buy
2024-02-22 Truist Securities Maintains Hold -> Hold
2023-12-06 JMP Securities Initiate Market Perform
2023-11-30 UBS Initiate Neutral
2023-11-29 Barrington Research Maintains Outperform -> Outperform
2023-11-03 Truist Securities Maintains Hold -> Hold
2023-11-03 Jefferies Downgrade Buy -> Hold
2023-10-05 Jefferies Maintains Buy -> Buy
2023-08-14 Barrington Research Maintains Outperform -> Outperform
2023-08-08 Credit Suisse Maintains Neutral -> Neutral
2023-06-26 William Blair Initiate Outperform
2023-06-01 Barrington Research Maintains Outperform -> Outperform
2023-05-05 Credit Suisse Maintains Neutral
2023-05-02 Truist Securities Maintains Hold
2023-03-10 Loop Capital Initiate Buy
2023-02-23 Benchmark Maintains Buy
2023-02-23 Credit Suisse Maintains Neutral
2022-11-07 Barrington Research Maintains Outperform
2022-10-05 Truist Securities Downgrade Buy -> Hold
2022-09-15 Benchmark Maintains Buy